vs
Side-by-side financial comparison of Ameris Bancorp (ABCB) and STEPAN CO (SCL). Click either name above to swap in a different company.
STEPAN CO is the larger business by last-quarter revenue ($604.5M vs $314.4M, roughly 1.9× Ameris Bancorp). Ameris Bancorp runs the higher net margin — 35.1% vs 3.3%, a 31.9% gap on every dollar of revenue. On growth, Ameris Bancorp posted the faster year-over-year revenue change (10.0% vs 1.9%). Over the past eight quarters, STEPAN CO's revenue compounded faster (4.2% CAGR vs 2.3%).
Ameris Bancorp is an American bank holding company headquartered in Atlanta, Georgia. Through its bank subsidiary, Ameris Bank, the company operates full-service branches in Georgia, Alabama, Florida, North Carolina and South Carolina, and mortgage-only locations in Georgia, Alabama, Florida, North Carolina, South Carolina, Virginia, Maryland, and Tennessee. The company offers online and mobile banking options for both consumers and businesses.
Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.
ABCB vs SCL — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $314.4M | $604.5M |
| Net Profit | $110.5M | $19.7M |
| Gross Margin | — | 10.7% |
| Operating Margin | — | 4.7% |
| Net Margin | 35.1% | 3.3% |
| Revenue YoY | 10.0% | 1.9% |
| Net Profit YoY | — | — |
| EPS (diluted) | $1.63 | $0.86 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $314.4M | $604.5M | ||
| Q4 25 | $307.1M | $553.9M | ||
| Q3 25 | $314.2M | $590.3M | ||
| Q2 25 | $300.7M | $594.7M | ||
| Q1 25 | $285.9M | $593.3M | ||
| Q4 24 | $290.8M | $525.6M | ||
| Q3 24 | $283.8M | $546.8M | ||
| Q2 24 | $300.6M | $556.4M |
| Q1 26 | $110.5M | $19.7M | ||
| Q4 25 | $108.4M | $5.0M | ||
| Q3 25 | $106.0M | $10.8M | ||
| Q2 25 | $109.8M | $11.3M | ||
| Q1 25 | $87.9M | $19.7M | ||
| Q4 24 | $94.4M | $3.4M | ||
| Q3 24 | $99.2M | $23.6M | ||
| Q2 24 | $90.8M | $9.5M |
| Q1 26 | — | 10.7% | ||
| Q4 25 | — | 9.3% | ||
| Q3 25 | — | 12.0% | ||
| Q2 25 | — | 12.1% | ||
| Q1 25 | — | 12.7% | ||
| Q4 24 | — | 10.8% | ||
| Q3 24 | — | 13.8% | ||
| Q2 24 | — | 12.5% |
| Q1 26 | — | 4.7% | ||
| Q4 25 | 45.9% | 1.9% | ||
| Q3 25 | 43.6% | 3.7% | ||
| Q2 25 | 47.4% | 3.0% | ||
| Q1 25 | 39.5% | 4.8% | ||
| Q4 24 | 43.3% | 1.5% | ||
| Q3 24 | 44.4% | 4.4% | ||
| Q2 24 | 42.1% | 3.4% |
| Q1 26 | 35.1% | 3.3% | ||
| Q4 25 | 44.2% | 0.9% | ||
| Q3 25 | 33.7% | 1.8% | ||
| Q2 25 | 36.5% | 1.9% | ||
| Q1 25 | 30.8% | 3.3% | ||
| Q4 24 | 42.5% | 0.6% | ||
| Q3 24 | 35.0% | 4.3% | ||
| Q2 24 | 30.2% | 1.7% |
| Q1 26 | $1.63 | $0.86 | ||
| Q4 25 | $1.59 | $0.22 | ||
| Q3 25 | $1.54 | $0.47 | ||
| Q2 25 | $1.60 | $0.50 | ||
| Q1 25 | $1.27 | $0.86 | ||
| Q4 24 | $1.35 | $0.14 | ||
| Q3 24 | $1.44 | $1.03 | ||
| Q2 24 | $1.32 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | $328.4M |
| Stockholders' EquityBook value | $4.1B | $1.2B |
| Total Assets | $28.1B | $2.3B |
| Debt / EquityLower = less leverage | — | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $132.7M | ||
| Q3 25 | — | $118.5M | ||
| Q2 25 | — | $88.9M | ||
| Q1 25 | — | $107.5M | ||
| Q4 24 | — | $99.7M | ||
| Q3 24 | — | $147.3M | ||
| Q2 24 | — | $124.7M |
| Q1 26 | — | $328.4M | ||
| Q4 25 | — | $626.7M | ||
| Q3 25 | — | $655.5M | ||
| Q2 25 | — | $658.0M | ||
| Q1 25 | — | $659.3M | ||
| Q4 24 | — | $625.4M | ||
| Q3 24 | — | $688.5M | ||
| Q2 24 | — | $657.1M |
| Q1 26 | $4.1B | $1.2B | ||
| Q4 25 | $4.1B | $1.2B | ||
| Q3 25 | $4.0B | $1.2B | ||
| Q2 25 | $3.9B | $1.2B | ||
| Q1 25 | $3.8B | $1.2B | ||
| Q4 24 | $3.8B | $1.2B | ||
| Q3 24 | $3.7B | $1.2B | ||
| Q2 24 | $3.6B | $1.2B |
| Q1 26 | $28.1B | $2.3B | ||
| Q4 25 | $27.5B | $2.4B | ||
| Q3 25 | $27.1B | $2.4B | ||
| Q2 25 | $26.7B | $2.4B | ||
| Q1 25 | $26.5B | $2.4B | ||
| Q4 24 | $26.3B | $2.3B | ||
| Q3 24 | $26.4B | $2.4B | ||
| Q2 24 | $26.5B | $2.3B |
| Q1 26 | — | 0.28× | ||
| Q4 25 | — | 0.50× | ||
| Q3 25 | — | 0.53× | ||
| Q2 25 | — | 0.53× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.53× | ||
| Q3 24 | — | 0.56× | ||
| Q2 24 | — | 0.55× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCB
Segment breakdown not available.
SCL
| Surfactants | $453.7M | 75% |
| Polymers | $130.0M | 22% |
| Specialty Products | $20.8M | 3% |
